登录 | 注册    关注公众号  
微信公众号
搜索
 > 【BTN3A1】

BTN3A1信息

英文名称:Butyrophilin subfamily 3 member A1
中文名称:嗜乳脂蛋白家族亚型3成员A1
靶点别称:BTF5,BTN3A1,CD_antigen,BTN3.1,BT3.1,DJ45P21.3 (Butyrophilin, Subfamily 3, Member A1),Butyrophilin, Subfamily 3, Member A1,CD277 Antigen
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

BTN3A1分子别名

BTN3A1,CD277,BTF5

BTN3A1分子背景

Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.

BTN3A1临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
ICT-01(Imcheck Therapeutics) ICT-01 临床二期 ImCheck Therapeutics SAS 实体瘤, 肿瘤, 淋巴瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定